Diseases [C] » Pathological Conditions, Signs and Symptoms [C23] » Signs and Symptoms » Neurologic Manifestations » Pain
Psychiatry and Psychology [F] » Psychological Phenomena [F02] » Psychophysiology » Sensation » Pain
Phenomena and Processes [G] » Musculoskeletal and Neural Physiological Phenomena [G11] » Nervous System Physiological Phenomena » Sensation » Pain
Description
An unpleasant sensation induced by noxious stimuli which are detected by NERVE ENDINGS of NOCICEPTIVE NEURONS. MeSH
Hierarchy View
Subtype Terms (28)
Abdominal Pain
97 drugs (58 approved, 39 experimental)
Acute Pain
144 drugs (99 approved, 45 experimental)
Arthralgia
67 drugs (34 approved, 33 experimental)
Back Pain
150 drugs (91 approved, 59 experimental)
Breakthrough Pain
15 drugs (12 approved, 3 experimental)
Cancer Pain
42 drugs (32 approved, 10 experimental)
Chest Pain
36 drugs (31 approved, 5 experimental)
Chronic Pain
191 drugs (123 approved, 68 experimental)
Earache
1 approved drug
Eye Pain
7 drugs (6 approved, 1 experimental)
Facial Pain
22 drugs (20 approved, 2 experimental)
Flank Pain
8 drugs (7 approved, 1 experimental)
Glossalgia
1 approved drug
Headache
134 drugs (97 approved, 37 experimental)
Labor Pain
45 drugs (35 approved, 10 experimental)
Mastodynia
17 drugs (13 approved, 4 experimental)
Musculoskeletal Pain
37 drugs (27 approved, 10 experimental)
Neck Pain
37 drugs (29 approved, 8 experimental)
Neuralgia
148 drugs (87 approved, 61 experimental)
Nociceptive Pain
16 drugs (12 approved, 4 experimental)
Pain, Intractable
26 drugs (24 approved, 2 experimental)
Pain, Postoperative
240 drugs (151 approved, 89 experimental)
Pain, Procedural
26 drugs (20 approved, 6 experimental)
Pain, Referred
4 drugs (3 approved, 1 experimental)
Pain Threshold
4 drugs (1 approved, 3 experimental)
Pelvic Pain
35 drugs (27 approved, 8 experimental)
Renal Colic
34 drugs (24 approved, 10 experimental)
Approved Indicated Drugs (130)
Phase 4 Indicated Drugs (133)
Phase 2 Indicated Drugs (138)
Phase 1 Indicated Drugs (61)
Organization Involved with Phase 4 Indications (17)
Organization Involved with Phase 3 Indications (19)
Organization Involved with Phase 2 Indications (39)
Organization Involved with Other Experimental Indications (6)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
